KR20080035637A - 엔,2,3-트리메틸-2-이소프로필부타미드의 국소 통증 경감조성물 및 그의 사용 방법 - Google Patents

엔,2,3-트리메틸-2-이소프로필부타미드의 국소 통증 경감조성물 및 그의 사용 방법 Download PDF

Info

Publication number
KR20080035637A
KR20080035637A KR1020087003791A KR20087003791A KR20080035637A KR 20080035637 A KR20080035637 A KR 20080035637A KR 1020087003791 A KR1020087003791 A KR 1020087003791A KR 20087003791 A KR20087003791 A KR 20087003791A KR 20080035637 A KR20080035637 A KR 20080035637A
Authority
KR
South Korea
Prior art keywords
pain
topical
composition
compositions
isopropylbutamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020087003791A
Other languages
English (en)
Korean (ko)
Inventor
주타로 슈도
유지 마치다
세이치로 카와바타
Original Assignee
테이코쿠 팔마 유에스에이, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 테이코쿠 팔마 유에스에이, 인코포레이티드 filed Critical 테이코쿠 팔마 유에스에이, 인코포레이티드
Publication of KR20080035637A publication Critical patent/KR20080035637A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
KR1020087003791A 2005-10-24 2006-10-16 엔,2,3-트리메틸-2-이소프로필부타미드의 국소 통증 경감조성물 및 그의 사용 방법 Ceased KR20080035637A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72984405P 2005-10-24 2005-10-24
US60/729,844 2005-10-24

Publications (1)

Publication Number Publication Date
KR20080035637A true KR20080035637A (ko) 2008-04-23

Family

ID=37968368

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087003791A Ceased KR20080035637A (ko) 2005-10-24 2006-10-16 엔,2,3-트리메틸-2-이소프로필부타미드의 국소 통증 경감조성물 및 그의 사용 방법

Country Status (15)

Country Link
US (1) US20070093555A1 (enExample)
EP (1) EP1940377A4 (enExample)
JP (2) JP5128483B2 (enExample)
KR (1) KR20080035637A (enExample)
CN (1) CN101534805A (enExample)
AR (1) AR058141A1 (enExample)
AU (1) AU2006306563B2 (enExample)
BR (1) BRPI0613067A2 (enExample)
CA (1) CA2614345C (enExample)
MX (1) MX2008000486A (enExample)
NZ (1) NZ564014A (enExample)
RU (1) RU2407522C2 (enExample)
TW (1) TWI372047B (enExample)
WO (1) WO2007050369A2 (enExample)
ZA (1) ZA200711041B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102621024B1 (ko) * 2023-09-12 2024-01-05 (주)진코스텍 심미감 및 피부 흡수력이 개선된 하이드로겔 패치

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080035637A (ko) * 2005-10-24 2008-04-23 테이코쿠 팔마 유에스에이, 인코포레이티드 엔,2,3-트리메틸-2-이소프로필부타미드의 국소 통증 경감조성물 및 그의 사용 방법
WO2011133177A1 (en) * 2010-04-21 2011-10-27 Teikoku Pharma Usa, Inc. Local anesthetic emulsion compositions and methods of making and using the same
TWI704933B (zh) 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
KR101831290B1 (ko) 2013-10-07 2018-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 조성물을 사용하여 주의력 결핍 과잉행동 장애, 불안 및 불면증을 치료하기 위한 방법 및 조성물
KR101891185B1 (ko) 2013-10-07 2018-08-24 테이코쿠 팔마 유에스에이, 인코포레이티드 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물
US20160158393A1 (en) * 2014-02-21 2016-06-09 Avadim Technologies, Inc. Method for Improving Health Outcomes
CA2939940C (en) 2014-02-21 2023-10-03 Avadim Technologies, Inc. Method for maintenance of urethral catheters
CA3143518A1 (en) 2019-06-12 2020-12-17 Avadim Health Ip, Inc. Compositions and methods for the antiseptic cleansing and biofilms treatment of mammalian tissue
WO2020257650A1 (en) * 2019-06-19 2020-12-24 Ganio Carl Formulations using lithium to treat gout arthropathy

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH10359A (en) 1971-02-04 1977-01-05 Wilkinson Sword Ltd N-substituted-p-methane-3-carboxamides having physiological cooling activity and compositions containing them
US4193936A (en) 1971-02-04 1980-03-18 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US4150052A (en) * 1971-02-04 1979-04-17 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US4060091A (en) 1972-01-28 1977-11-29 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
US4059118A (en) 1972-01-28 1977-11-22 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
US4033994A (en) * 1972-01-28 1977-07-05 Wilkinson Sword Limited Substituted p-menthanes
GB1421743A (en) 1972-04-18 1976-01-21 Wilkinson Sword Ltd Ingestible topical and other compositions
US4153679A (en) 1972-04-18 1979-05-08 Wilkinson Sword Limited Acyclic carboxamides having a physiological cooling effect
CA1027347A (en) 1972-07-20 1978-03-07 David G. Rowsell Compounds having a physiological cooling effect and compositions containing them
BE802469A (fr) * 1972-07-20 1974-01-18 Wilkinson Sword Ltd Perfectionnements apportes et/ou relatifs a des composes exercant un effet refrigerant physiologique et compositions contenant ceux-ci
GB1434728A (en) * 1972-09-27 1976-05-05 Wilkinson Sword Ltd Compositions and articles containing phospine oxides having a physiological cooling effect and phosphine oxides for use therein
US4070449A (en) * 1972-10-24 1978-01-24 Wilkinson Sword Limited Compounds having a physiological cooling effect and compositions containing them
US4034109A (en) * 1973-01-18 1977-07-05 Wilkinson Sword Limited Compounds having a physiological cooling effect and compositions containing them
US4296093A (en) * 1973-04-16 1981-10-20 Wilkinson Sword Limited Cyclic carboxamides having a physiological cooling effect
US4172887A (en) * 1973-11-30 1979-10-30 L'oreal Hair conditioning compositions containing crosslinked polyaminopolyamides
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル
US5120544A (en) 1989-06-19 1992-06-09 Henley International, Inc. Crosslinked hydrogel and method for making same
US5270358A (en) 1989-12-28 1993-12-14 Minnesota Mining And Manufacturing Company Composite of a disperesed gel in an adhesive matrix
US5148804A (en) * 1990-06-28 1992-09-22 Hill Dennis M Device, system, and methods for applying cryotherapy
JP3115625B2 (ja) 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
DE4110973A1 (de) * 1991-04-05 1992-10-08 Haarmann & Reimer Gmbh Mittel mit physiologischem kuehleffekt und fuer diese mittel geeignete wirksame verbindungen
US5160328A (en) 1991-08-07 1992-11-03 Ndm Acquisition Corp. Hydrogel bandage
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
ES2105293T3 (es) * 1992-06-17 1997-10-16 Procter & Gamble Composiciones refrescantes con efecto irritante reducido.
CA2160874C (en) * 1993-04-30 1999-05-11 William Fletcher Beck Nasal aromatic releasing compositions
US5760085A (en) * 1993-04-30 1998-06-02 The Procter & Gamble Company Topical aromatic releasing compositions
NZ250994A (en) 1993-05-27 1995-09-26 Ndm Acquisition Corp Wound dressing comprising a hydrogel layer bound to a porous backing layer which is bound to a thin film layer by adhesive
US5423737A (en) 1993-05-27 1995-06-13 New Dimensions In Medicine, Inc. Transparent hydrogel wound dressing with release tab
JP2978043B2 (ja) * 1993-09-16 1999-11-15 高砂香料工業株式会社 （２ｓ）−３−｛（１ｒ，２ｓ，５ｒ）−［ ５−メチル−２−（１−メチルエチル）シクロヘキシル ］オキシ｝−１，２−プロパンジオール，その製造方法および用途
US5407665A (en) * 1993-12-22 1995-04-18 The Procter & Gamble Company Ethanol substitutes
US5536263A (en) 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
JP3241542B2 (ja) * 1994-07-29 2001-12-25 高砂香料工業株式会社 （−）−ｎ−イソプレゴールの精製方法及びその方法で得られた（−）−ｎ−イソプレゴールを含有するシトラス系香料組成物
KR100209469B1 (ko) * 1994-10-05 1999-07-15 나까도미 히로다카 N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형 제제
US5853768A (en) * 1995-03-01 1998-12-29 Altadonna; James Topical preparation and method for pain relief
DE69625549T2 (de) * 1995-06-27 2003-05-15 Kao Corp., Tokio/Tokyo Pflaster mit wasserlöslicher Klebeschicht
US6039940A (en) 1996-10-28 2000-03-21 Ballard Medical Products Inherently antimicrobial quaternary amine hydrogel wound dressings
US6769428B2 (en) 1997-01-29 2004-08-03 Peter J. Cronk Adhesively applied external nasal strips and dilators containing medications and fragrances
US6244265B1 (en) * 1997-01-29 2001-06-12 Peter J. Cronk Adhesively applied external nasal strips and dilators containing medications and fragrances
WO1999007342A1 (en) * 1997-08-11 1999-02-18 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
US6455080B1 (en) * 1997-12-29 2002-09-24 Wm. Wrigley Jr., Company Chewing gum containing controlled release acyclic carboxamide and method of making
US20020013304A1 (en) * 1997-10-28 2002-01-31 Wilson Leland F. As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
JP3450680B2 (ja) 1997-10-28 2003-09-29 高砂香料工業株式会社 パラ−メンタン−３，８−ジオールの製造方法
EP1034161B2 (fr) * 1997-11-27 2006-03-15 Firmenich Sa Nouveaux composes derives du menthol et leur utilisation en tant qu'agent rafraichissant
JP4017758B2 (ja) * 1998-08-04 2007-12-05 高砂香料工業株式会社 冷感剤組成物
US6656456B2 (en) * 1998-11-23 2003-12-02 The Procter & Gamble Company Skin deodorizing compositions
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
EP1541039B1 (en) 1999-03-31 2008-01-02 Firmenich Sa Flavour composition comprising cubebol and a further refreshing agent
US6267974B1 (en) * 1999-04-16 2001-07-31 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic compositions with sensate mixtures based on isopulegol
US6348212B2 (en) 1999-05-18 2002-02-19 Lectec Corporation Treating traumatic burns or blisters of the skin
US6455065B1 (en) 1999-05-18 2002-09-24 Lectec Corporation Therapeutic method for treating acne or isolated pimples and adhesive patch therefor
US6296869B1 (en) 1999-07-30 2001-10-02 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Adhesive cosmetic patch containing alpha or beta hydroxy acids
EP1217975A1 (en) * 1999-09-08 2002-07-03 Watson Pharmaceuticals, Inc. Using quaternary ammonium salts for transdermal drug delivery
EP1227788B1 (en) 1999-11-12 2010-08-11 The Procter & Gamble Company Oral compositions containing stannous ions
US6677391B1 (en) 1999-12-08 2004-01-13 The Procter & Gamble Company Tartar control denture adhesive compositions
ATE380474T1 (de) * 2000-05-23 2007-12-15 Nestle Sa Verwendung von alpha-ketoenaminderivaten als kühlende mittel
AU2001268451A1 (en) * 2000-06-13 2001-12-24 Fd Management, Inc. Cosmetic composition for stressed skin under extreme conditions
US6497859B1 (en) 2000-11-17 2002-12-24 Noville Inc. Cooling agents, pharmaceutical compositions having cooling agents and processes for making and using same
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics
US20020143047A1 (en) * 2001-01-05 2002-10-03 Galer Bradley S. Methods for treating indomethacin responsive headaches
US6761900B2 (en) * 2001-03-12 2004-07-13 Teikoku Pharma Usa, Inc. Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
US6514484B2 (en) 2001-03-19 2003-02-04 The Procter & Gamble Company Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier
EP1245240A1 (en) 2001-03-30 2002-10-02 The Procter & Gamble Company Skin-compatible hydrogel adhesives and personal care products containing them
CN100408016C (zh) 2001-06-25 2008-08-06 宝洁公司 口腔组合物
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
JP2004059474A (ja) 2002-07-26 2004-02-26 T Hasegawa Co Ltd ｐ−メンタン誘導体およびこれを含有する冷感剤
GB0221697D0 (en) 2002-09-18 2002-10-30 Unilever Plc Novel compouds and their uses
GB0315974D0 (en) 2003-07-08 2003-08-13 Coolanalgesia Ltd Cooling device for pain relief
WO2005060550A2 (en) * 2003-12-11 2005-07-07 Teikoku Pharma Usa, Inc. Methods and compositions for treating skin wounds
US7482378B2 (en) * 2004-05-28 2009-01-27 Millenium Specialty Chemicals, Inc. Physiological cooling compositions
PL1833443T3 (pl) * 2005-01-04 2012-04-30 Teikoku Pharma Usa Inc Miejscowy preparat chłodzący w postaci plastra
US20070259354A1 (en) * 2005-10-11 2007-11-08 Senomyx, Inc. Optimized trpm8 nucleic acid sequences and their use in cell based assays and test kits to identify trpm8 modulators
KR20080035637A (ko) * 2005-10-24 2008-04-23 테이코쿠 팔마 유에스에이, 인코포레이티드 엔,2,3-트리메틸-2-이소프로필부타미드의 국소 통증 경감조성물 및 그의 사용 방법
US20070185237A1 (en) * 2005-11-09 2007-08-09 Jayanth Rajaiah Denture adhesive articles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102621024B1 (ko) * 2023-09-12 2024-01-05 (주)진코스텍 심미감 및 피부 흡수력이 개선된 하이드로겔 패치

Also Published As

Publication number Publication date
AR058141A1 (es) 2008-01-23
CA2614345C (en) 2013-01-08
CA2614345A1 (en) 2007-05-03
AU2006306563A1 (en) 2007-05-03
AU2006306563B2 (en) 2009-10-01
ZA200711041B (en) 2009-08-26
TW200731965A (en) 2007-09-01
JP2012197301A (ja) 2012-10-18
JP5128483B2 (ja) 2013-01-23
RU2407522C2 (ru) 2010-12-27
WO2007050369A3 (en) 2009-04-30
EP1940377A2 (en) 2008-07-09
JP2009515829A (ja) 2009-04-16
RU2008117760A (ru) 2009-12-10
WO2007050369A2 (en) 2007-05-03
TWI372047B (en) 2012-09-11
NZ564014A (en) 2011-10-28
US20070093555A1 (en) 2007-04-26
BRPI0613067A2 (pt) 2010-12-21
CN101534805A (zh) 2009-09-16
EP1940377A4 (en) 2010-12-08
JP5508477B2 (ja) 2014-05-28
MX2008000486A (es) 2008-03-07

Similar Documents

Publication Publication Date Title
JP5508477B2 (ja) Ｎ，２，３−トリメチル−２−イソプロピルブタナミドの局所用疼痛緩和用組成物並びにその使用法
US6528076B2 (en) Topical compositions and methods for treating pain
ES2620389T3 (es) Formulaciones tópicas de co-enzima Q10 y tratamiento de dolor, fatiga y heridas
US12109181B2 (en) Lidocaine patch and methods of use thereof
JP2003512401A (ja) 外科的に閉じた創傷部からの疼痛の局所的抑制または改善
WO2008027203A2 (en) Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue
WO2006017632A1 (en) An analgesic patch for sports injury and rehabilitation medicine and method to alleviate pain
CN102223889A (zh) 顺势疗法的治疗方法
US9186273B2 (en) Methods of treating pains associated with neuroma, nerve entrapment, and other conditions
CN103271997B (zh) 一种温经通络活血止痛热磁治疗贴
Sharma et al. Protocol based management of common sports injuries by integrated approach of Sandhi Marmabhighata-An open labeled clinical trial
AU2015200633A1 (en) Methods for treating pains associated with neuroma, nerve entrapment, and other conditions
Gargya et al. Peripheral nerve stimulator for chronic pain from quadriceps tendon rupture: a case report
RU2489180C1 (ru) Способ лечения компрессионного перелома позвоночника у детей
RU2274472C1 (ru) Способ лечения дегенеративных заболеваний опорно-двигательного аппарата и посттравматических болевых синдромов
Moshref Topical zinc oxide adhesive tape for keloid management
RU2436584C1 (ru) Способ лечения дегеративно-дистрофических заболеваний опорно-двигательного аппарата и посттравматических спаечных процессов
RU2341285C1 (ru) Набор для лечения заболеваний, вызванных патологическим изменением хрящевой и/или костной ткани, и способ его применения
JP2000159664A (ja) 脂肪減少用外用剤及び脂肪減少装置
JP3036689U (ja) 蓐瘡等の治療用貼付材
CN119868435A (zh) 治疗陈旧性踝关节扭伤的中药组合物和中药膏摩剂
Aydog et al. The role of infrared and ultrasound waves in the treatment of calcaneal spur
JP2009191073A (ja) 脂肪減少用外用剤及び脂肪減少装置
US20060182819A1 (en) Soap scent patch and treatment for muscle spasm and pain
CA2734300A1 (en) Heat assisted lidocaine and tetracaine for transdermal analgesia

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080218

Patent event code: PA01051R01D

Comment text: International Patent Application

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20080317

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20100121

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20100902

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20100121

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20101203

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20100902

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20110623

Appeal identifier: 2010101009351

Request date: 20101203

A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20110103

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20110103

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20101203

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20100721

Patent event code: PB09011R02I

B601 Maintenance of original decision after re-examination before a trial
PB0601 Maintenance of original decision after re-examination before a trial

Comment text: Report of Result of Re-examination before a Trial

Patent event code: PB06011S01D

Patent event date: 20110131

J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20101203

Effective date: 20110623

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20110623

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20101203

Decision date: 20110623

Appeal identifier: 2010101009351

J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

PJ2001 Appeal

Patent event date: 20110623

Comment text: Trial Decision on Objection to Decision on Refusal

Patent event code: PJ20011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20120328

Appeal identifier: 2011201008006

Request date: 20110819

J2X2 Appeal (before the supreme court)

Free format text: APPEAL BEFORE THE SUPREME COURT FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL

PJ2002 Appeal before the supreme court

Comment text: Trial Decision on Objection to Decision on Refusal

Patent event date: 20110623

Patent event code: PJ20021S01I

Request date: 20120416

Appeal identifier: 2012301001408

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20120823

J302 Written judgement (patent court)

Free format text: JUDGMENT (PATENT COURT) FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20110819

Effective date: 20120328

PJ1302 Judgment (patent court)

Patent event date: 20120830

Comment text: Written Judgment (Patent Court)

Patent event code: PJ13021S01D

Request date: 20110819

Decision date: 20120328

Appeal identifier: 2011201008006

Appeal kind category: Appeal against decision to decline refusal